Puma Biotechnology, Inc. (PBYI)

NASDAQ: PBYI · Real-Time Price · USD

5.30

+0.43 (8.83%)

At close: Aug 13, 2025, 4:00 PM

5.27

-0.03 (-0.57%)

Pre-market: Aug 14, 2025, 8:58 AM EDT

Puma Biotechnology Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	238.06	230.47	235.64	228.03	253.16	225.11	Upgrade
Revenue Growth (YoY)	8.63%	-2.19%	3.34%	-9.92%	12.46%	-17.32%	Upgrade
Cost of Revenue	65.88	64.4	62.68	55.09	63.7	39.37	Upgrade
Gross Profit	172.19	166.06	172.96	172.94	189.45	185.74	Upgrade
Selling, General & Admin	69.09	80.16	89.31	89.98	116.29	118.49	Upgrade
Research & Development	57.03	54.94	50.38	52.24	71.87	97.65	Upgrade
Operating Expenses	126.12	135.1	139.69	142.22	188.16	216.14	Upgrade
Operating Income	46.06	30.97	33.27	30.72	1.29	-30.4	Upgrade
Interest Expense	-9.74	-12.45	-13.33	-11.59	-12.81	-14.05	Upgrade
Interest & Investment Income	4.57	4.72	2.61	0.81	0.16	0.49	Upgrade
Other Non Operating Income (Expenses)	1.38	0.86	0.76	-0.03	0.29	0.37	Upgrade
EBT Excluding Unusual Items	42.28	24.1	23.3	19.91	-11.07	-43.59	Upgrade
Asset Writedown	-	-	-0.63	-	-	-	Upgrade
Legal Settlements	-	-	-	-12.46	-9.59	-16.2	Upgrade
Other Unusual Items	-	-	-	-	-8.15	-	Upgrade
Pretax Income	42.28	24.1	22.67	0.46	-28.8	-59.79	Upgrade
Income Tax Expense	-6.17	-6.18	1.08	0.46	0.32	0.21	Upgrade
Net Income	48.45	30.28	21.59	0	-29.13	-60	Upgrade
Net Income to Common	48.45	30.28	21.59	0	-29.13	-60	Upgrade
Net Income Growth	455.63%	40.23%	1079450.00%	-	-	-	Upgrade
Shares Outstanding (Basic)	49	49	47	45	41	40	Upgrade
Shares Outstanding (Diluted)	50	49	48	45	41	40	Upgrade
Shares Change (YoY)	3.94%	3.26%	5.83%	10.56%	2.69%	2.08%	Upgrade
EPS (Basic)	0.98	0.62	0.46	0.00	-0.72	-1.52	Upgrade
EPS (Diluted)	0.97	0.62	0.45	0.00	-0.72	-1.52	Upgrade
EPS Growth	434.29%	37.78%	1022625.00%	-	-	-	Upgrade
Free Cash Flow	44.22	38.86	26.87	-15.83	20.65	0.73	Upgrade
Free Cash Flow Per Share	0.89	0.79	0.56	-0.35	0.51	0.02	Upgrade
Gross Margin	72.33%	72.06%	73.40%	75.84%	74.84%	82.51%	Upgrade
Operating Margin	19.35%	13.44%	14.12%	13.47%	0.51%	-13.51%	Upgrade
Profit Margin	20.35%	13.14%	9.16%	0.00%	-11.51%	-26.65%	Upgrade
Free Cash Flow Margin	18.58%	16.86%	11.40%	-6.94%	8.16%	0.32%	Upgrade
EBITDA	57.34	42.49	44.78	40.56	12.6	-20.37	Upgrade
EBITDA Margin	24.09%	18.44%	19.01%	17.79%	4.98%	-9.05%	Upgrade
D&A For EBITDA	11.28	11.52	11.52	9.84	11.31	10.03	Upgrade
EBIT	46.06	30.97	33.27	30.72	1.29	-30.4	Upgrade
EBIT Margin	19.35%	13.44%	14.12%	13.47%	0.51%	-13.51%	Upgrade
Effective Tax Rate	-	-	4.78%	99.56%	-	-	Upgrade
Revenue as Reported	238.06	230.47	235.64	228.03	253.16	225.11	Upgrade

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q